Chas Taylor

Chas Taylor MBA Chas has recently joined Vasorum as an Executive Director to oversee market and corporate development. He has extensive experience in the cardiovascular market space. He has founded and sold three companies; MedNova in 1996 (acquired by Abbott in 2002), Novate Medical in 2006 (acquired by BTG in 2018) and Veryan Medical In 2007 (acquired by Otsuka in 2019). Prior to his experience in start-ups he held senior VP positions at US Divisions of CR Bard where he worked for 12 years. Chas has a MBA from Henley Management College, Brunel University, UK.